USC's Keck School of Medicine partners with StemCardia to advance heart failure treatment
The Keck School of Medicine of USC has launched a strategic collaboration with StemCardia, a biotechnology company, founded by a Keck School of Medicine faculty member, that develops cellular and genetic therapies to address heart failure.
8 Oct 23:28 · News-Medical